  Proton beam therapy has been developed to irradiate the tumor with higher
precision and dose conformity compared to conventional X-ray irradiation. The
dose conformity of this treatment modality may be further improved if narrower
proton beams are used. Still, this is limited by multiple Coulomb scattering of
protons through tissue. The primary aim of this work was to develop techniques
to produce narrow proton beams and investigate the resulting dose profiles. We
introduced and assessed three different proton beam shaping techniques: 1)
metal collimators (100/150~MeV), 2) focusing of conventional- (100/150~MeV),
and 3) focusing of high-energy (350~MeV, shoot-through) proton beams. Focusing
was governed by the initial value of the Twiss parameter $\alpha$~($\alpha_0$),
and can be implemented with magnetic particle accelerator optics. The dose
distributions in water were calculated by Monte Carlo simulations using Geant4,
and evaluated by target to surface dose ratio (TSDR) in addition to the
transverse beam size~($\sigma_T$) at the target. The target was defined as the
location of the Bragg peak or the focal point. The different techniques showed
greatly differing dose profiles, where focusing gave pronouncedly higher
relative target dose and efficient use of primary protons. Metal collimators
with radii < 2~mm gave low TSDRs (<~0.7) and large $\sigma_T$(>~3.6~mm). In
contrast, a focused beam of conventional (150~MeV) energy produced a very high
TSDR (>~80) with similar $\sigma_T$ as a collimated beam. High-energy focused
beams were able to produce TSDRs > 100 and $\sigma_T$ around 1.5~mm. From this
study, it appears very attractive to implement magnetically focused proton
beams in radiotherapy of small lesions or tumors in close vicinity to healthy
organs at risk. This can also lead to a paradigm change in spatially
fractionated radiotherapy.
